Bioactive Materials, Год журнала: 2025, Номер 49, С. 218 - 254
Опубликована: Март 10, 2025
Язык: Английский
Bioactive Materials, Год журнала: 2025, Номер 49, С. 218 - 254
Опубликована: Март 10, 2025
Язык: Английский
Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)
Опубликована: Янв. 20, 2025
Язык: Английский
Процитировано
3European Journal of Pharmaceutics and Biopharmaceutics, Год журнала: 2025, Номер unknown, С. 114650 - 114650
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Phytomedicine, Год журнала: 2025, Номер 139, С. 156496 - 156496
Опубликована: Фев. 11, 2025
Язык: Английский
Процитировано
0Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 329 - 329
Опубликована: Март 3, 2025
Objectives: Liposomes are a promising drug carrier for inhaled delivery systems and their physical parameters could influence therapeutic efficacy significantly. This study was designed to answer the specific question of proper surface charge liposomes in pulmonary inhalation, as well synergistic anti-inflammation between drugs. Methods: In this work, series drug-loaded with different charges (from negative positive) were prepared, several vitro vivo assays, including cytotoxicity, hemolysis assay, mucus penetration lipopolysaccharide (LPS)-induced pneumonia model test, adopted evaluate biocompatibility above liposomes. Results: Compared cationic liposomes, anionic capable better good (low blood compatibility mild tissue inflammation), but poor cellular uptake by immune cells. specific, even when liposome only +2.6 mV, its cytotoxicity reached around 20% 15%, respectively. Furthermore, there no significant difference (−25.9 vs. −2.5 mV), slightly negative-charged exhibited uptake. Conclusions: Thus, (−1~−3 mV) be considering both biocompatibility. an LPS-induced mouse model, achieved anti-inflammatory compared free
Язык: Английский
Процитировано
0Bioactive Materials, Год журнала: 2025, Номер 49, С. 218 - 254
Опубликована: Март 10, 2025
Язык: Английский
Процитировано
0